NCT05765396View on ClinicalTrials.gov

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies

RecruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

March 30, 2025

Study Completion Date

April 30, 2025

Conditions
COVID-19SARS-CoV-2 VirusCOVID-19 PneumoniaCOVID-19 Respiratory InfectionCOVID-19 Acute Respiratory Distress SyndromeCorona Virus InfectionInfluenzaRSV Infection
Interventions
DEVICE

imPulse™ Systems (Una and TOR) infrasound-to-ultrasound e-stethoscope

The imPulse™ Systems are an every/anywhere-point-of-care cardiopulmonary functional state assessment platform designed to capture normal and abnormal, audible and inaudible cardiopulmonary sounds, rhythms and patterns, via a real-time, intelligent, full-spectrum phonocardiogram obtained from direct to skin coupling or through a layer of clothing.

Trial Locations (1)

78234

RECRUITING

Brooke Army Medical Center, Fort Sam Houston

All Listed Sponsors
collaborator

Brooke Army Medical Center

FED

collaborator

Uniformed Services University of the Health Sciences

FED

collaborator

Level 42 AI, Inc.

INDUSTRY

lead

The Geneva Foundation

OTHER